Evidence map›Paper›PMID 42129166›Full record

ArticleNature communications2026

Structural basis of Ku-mediated activation of WRN exonuclease activity.

Sayma Zahid, Jeanne Chauvat, Ilaria Ceppi, Floriana Cappiello, Benedetta Perdichizzi, Philippe Frit, Dennis Gomez, Steven W Hardwick, Pierre Legrand, Julien Karazi and 9 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Sayma Zahid *Université Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0002-1354-9209
Jeanne Chauvat *Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0002-2409-6874
Ilaria Ceppi *Institute for Research in Biomedicine, Università della Svizzera italiana (USI), Faculty of Biomedical Sciences, Bellinzona, Switzerland.ORCID http://orcid.org/0000-0001-6496-8983
Floriana Cappiello *Mechanisms, Biomarkers and Models Section, Genome Stability Group, Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.ORCID http://orcid.org/0000-0003-3423-8474
Benedetta Perdichizzi *Mechanisms, Biomarkers and Models Section, Genome Stability Group, Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy.
Philippe FritInstitut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0002-6571-8860
Dennis GomezInstitut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0001-9942-1451
Steven W HardwickCryo-EM Facility, Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge, CB2 1GA, UK.ORCID http://orcid.org/0000-0001-9246-1864
Pierre LegrandSynchrotron SOLEIL, l'Orme des Merisiers, Saint Aubin, France.ORCID http://orcid.org/0000-0003-2431-2255
Julien KaraziUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID http://orcid.org/0009-0007-5925-7889
Sonia BaconnaisGenome Integrity and Cancer UMR 9019 CNRS, Université Paris-Saclay, Gustave Roussy, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Gérard Pehau-ArnaudetUTECH UBI, Institut Pasteur and CNRS UMR, 3528, Paris, France.
Sébastien BrittonInstitut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.ORCID http://orcid.org/0000-0002-7008-5316
Jean-Baptiste CharbonnierUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France.ORCID http://orcid.org/0000-0002-5219-1983
Amanda K ChaplinCryo-EM Facility, Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge, CB2 1GA, UK. ac853@leicester.ac.uk.ORCID http://orcid.org/0000-0002-9606-8346
Pietro PichierriMechanisms, Biomarkers and Models Section, Genome Stability Group, Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy. pietro.pichierri@iss.it.ORCID http://orcid.org/0000-0002-2702-3523
Petr CejkaInstitute for Research in Biomedicine, Università della Svizzera italiana (USI), Faculty of Biomedical Sciences, Bellinzona, Switzerland. petr.cejka@irb.usi.ch.ORCID http://orcid.org/0000-0002-9087-032X
Patrick CalsouInstitut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France. calsou@ipbs.fr.ORCID http://orcid.org/0000-0001-7951-9806
Virginie RoparsUniversité Paris-Saclay, CEA, CNRS, Institute for Integrative Biology of the Cell (I2BC), 91198, Gif-sur-Yvette, France. virginie.ropars@cea.fr.ORCID http://orcid.org/0000-0002-3372-6030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Werner (WRN) is the only human RecQ helicase family member with DNA exonuclease activity. WRN promotes genome stability through its functions in DNA replication, repair and telomere maintenance, the deficiency of which presents clinically as Werner syndrome, causing premature aging and cancer predisposition. The main DNA double strand-break sensor Ku70/80 heterodimer (Ku) is a known partner of WRN, which stimulates its nuclease activity. However, the molecular basis of Ku-WRN interplay is currently unknown. Here, we present a high resolution cryo-EM structure of human Ku bound to DNA in complex with the N-terminal WRN exonuclease domain. This structure reveals multiple interaction sites between WRN and the Ku:DNA complex. The catalytic domain of WRN-exo engages with the DNA ends, stabilized by the vWA-like Ku80 domain interacting with the N-terminal APLF-like Ku binding motif (A-KBM) of WRN. Most surprisingly, we visualize the SAP domain of Ku70 stabilized within this complex, and we identify specific contacts mediating this interaction. These interactions are validated by assessing the impact of point mutations on either side of the Ku-WRN interfaces on exonuclease activity with purified recombinant proteins, and on live protein recruitment at biphoton laser-damaged nuclear sites. Finally, we show that disruption of WRN-Ku70 interaction results in aberrant resection of stalled replication forks. Together, we define the architecture of the Ku-WRN exonuclease domain interface and its impact on WRN exonuclease activity, recruitment and replication fork processing.

Indexed as

Ku AutoantigenWerner Syndrome HelicaseBinding SitesCatalytic DomainCryoelectron MicroscopyDNADNA RepairDNA ReplicationHumansModels, MolecularProtein BindingProtein DomainsDNAKu AutoantigenWerner Syndrome HelicaseWRN protein, humanXrcc6 protein, human

Identifiers

PMID42129166
PMCPMC13377182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.